All In MedTech

Device Trial Radar · NCT06303063

Compare the Safety and Effectiveness of Two Different Kinds of Stent System in Intracranial Aneurysms

A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the SINOMED IAS for the Treatment of Intracranial Aneurysms

Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 203 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

203

Actual

Start

Jan 17, 2024

Primary completion

Nov 20, 2025

Study completion Nov 20, 2025

Sponsor

Lead sponsor
Sinomed Neurovita Technology Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 12, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to evaluate the safety and efficacy of SINOMED IAS in patients with intracranial aneurysms.

Conditions

  • Intracranial Aneurysm

Interventions

  • SINOMED IAS Stent SystemDevice

    Stent-assisted coiling (SAC) of intracranial aneurysms paved the way for endovascular coiling of wide-neck aneurysms, improving rates of aneurysm obliteration and recurrence.

  • Neuroform Atlas Stent SystemDevice

    Stent-assisted coiling (SAC) of intracranial aneurysms paved the way for endovascular coiling of wide-neck aneurysms, improving rates of aneurysm obliteration and recurrence.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary efficacy endpoint is complete aneurysm occlusion without retreatment or significant parent artery stenosis at 12 months post-procedureTime frame: 12 months post-procedure

1 more outcomes with a free account

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, China

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.